Compare Agilent Technologies Inc (A) vs State Street SPDR Bloomberg High Yield Bond ETF (JNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs State Street SPDR Bloomberg High Yield Bond ETF — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.00B), while State Street SPDR Bloomberg High Yield Bond ETF trades at $95.74. The key difference: Agilent Technologies Inc pays a 0.69% dividend while State Street SPDR Bloomberg High Yield Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, State Street SPDR Bloomberg High Yield Bond ETF nearer its low. Which is the better fit depends on your goals.
| A | JNK | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Fixed Income |
52-Week High | $157.20 | $98.19 |
52-Week Low | $110.24 | $94.66 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
JNK trades at $95.81, up 0.21% today, with a bearish technical signal driven by moving averages. Key support sits at $95 and resistance at $96. The ETF provides high-yield bond exposure, with recent dividends of $0.52-$0.53 paid quarterly. News highlights focus on bond market volatility, inflation concerns, and AI-related credit risks impacting junk bonds.
Outlook is cautious due to rising Treasury yields and inflation fears pressuring high-yield bonds. Opportunities exist for income-seeking investors amid higher yields, but risks include Fed rate hike uncertainty and elevated oil prices affecting corporate credit. Investor sentiment is mixed, with inflows into bond ETFs offset by macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About State Street SPDR Bloomberg High Yield Bond ETF
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →
